|
Apr 4
|
UPDATE 2-Cyclicals drive modest gains across European stocks
|
|
Apr 3
|
Sanofi to Settle Claims That Heartburn Drug Zantac Caused Cancer
|
|
Apr 3
|
UPDATE 1-Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts
|
|
Mar 28
|
Why Is Denali Therapeutics (DNLI) Up 2.8% Since Last Earnings Report?
|
|
Mar 26
|
32 Countries with the Highest Rates of Diabetes
|
|
Mar 22
|
Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript
|
|
Mar 22
|
Press Release: Availability of the Q1 2024 Memorandum for modelling purposes
|
|
Mar 21
|
Mirador Therapeutics raises over $400 mln in early funding rounds
|
|
Mar 15
|
Sanofi: Information concerning the total number of voting rights and shares - February 2024
|
|
Mar 15
|
PE Firms Eye €7.5 Billion Buyout Financing for Sanofi Unit
|
|
Mar 14
|
12 Most Profitable Biotech Stocks To Invest In
|
|
Mar 12
|
ASLAN (ASLN) Up 161% on Upbeat Initial Data From Eczema Study
|
|
Mar 11
|
Press Release: New Phase 2b results for amlitelimab support potential for best-in-class maintenance of response in atopic dermatitis
|
|
Mar 7
|
UPDATE 2-Astra-Sanofi's RSV therapy 90% effective against infant hospitalizations, CDC study shows
|
|
Mar 5
|
13 Best Pharma Dividend Stocks To Buy in 2024
|
|
Feb 3
|
Q4 2023 Regeneron Pharmaceuticals Inc Earnings Call
|
|
Feb 2
|
Regeneron (REGN) Q4 Earnings & Sales Top, Eylea Sales Decline
|
|
Feb 2
|
Sanofi (NASDAQ:SNY) Q4 2023 Earnings Call Transcript
|
|
Feb 2
|
Pharma Stock Roundup: PFE, MRK, NVO & SNY's Q4 Earnings, FDA Updates
|
|
Feb 1
|
Sanofi's Biggest Drug Shined. But The Rest Of Its Business Didn't.
|